NEW YORK (GenomeWeb) – NEW YORK (GenomeWeb) – Sigma-Aldrich today reported a 3 percent increase in sales in the second quarter as revenues rose to $701 million from $681 million in the year-ago period.

Analysts on average had expected the firm to report $705.9 million for the quarter, which ended on June 30.

Sales in Sigma-Aldrich's Research business ticked up 1 percent year over year to $357 million from $353 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.